ReShape Lifesciences Inc. (NASDAQ:RSLS) Short Interest Update

ReShape Lifesciences Inc. (NASDAQ:RSLS) was the recipient of a large growth in short interest during the month of February. As of February 15th, there was short interest totalling 82,800 shares, a growth of 266.4% from the January 31st total of 22,600 shares. Approximately 62.6% of the company’s shares are sold short. Based on an average daily trading volume, of 930,400 shares, the short-interest ratio is currently 0.1 days.

ReShape Lifesciences Trading Down 6.4 %

NASDAQ RSLS opened at $1.03 on Friday. The business’s 50-day moving average price is $3.54 and its two-hundred day moving average price is $5.52. ReShape Lifesciences has a 12 month low of $0.98 and a 12 month high of $29.00.

About ReShape Lifesciences

ReShape Lifesciences Inc provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus.